These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fluoroquinolones for the treatment of nongonococcal urethritis/cervicitis. Segreti J. Am J Med; 1991 Dec 30; 91(6A):150S-152S. PubMed ID: 1662887 [Abstract] [Full Text] [Related]
6. Drug not considered a first-line agent. Lexchin J. Can Fam Physician; 1998 Nov 30; 44():2376. PubMed ID: 9839049 [No Abstract] [Full Text] [Related]
7. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis. Langan CE, Cranfield R, Breisch S, Pettit R. J Antimicrob Chemother; 1997 Dec 30; 40 Suppl A():63-72. PubMed ID: 9484875 [Abstract] [Full Text] [Related]
8. Sparfloxacin and levofloxacin. Med Lett Drugs Ther; 1997 Apr 25; 39(999):41-3. PubMed ID: 9137295 [No Abstract] [Full Text] [Related]
9. Pharmacokinetic study of a new quinolone, DW-116. Lee DK. Drugs; 1995 Apr 25; 49 Suppl 2():323-5. PubMed ID: 8549349 [No Abstract] [Full Text] [Related]
10. Two new fluoroquinolones. Med Lett Drugs Ther; 1992 Jun 12; 34(872):58-60. PubMed ID: 1317502 [No Abstract] [Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis. Forrest A, Chodosh S, Amantea MA, Collins DA, Schentag JJ. J Antimicrob Chemother; 1997 Dec 12; 40 Suppl A():45-57. PubMed ID: 9484873 [Abstract] [Full Text] [Related]
12. Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables. Tran JQ, Ballow CH, Forrest A, Hyatt JM, Sands MF, Peloquin CA, Schentag JJ. J Antimicrob Chemother; 2000 Mar 12; 45():9-17. PubMed ID: 10719007 [Abstract] [Full Text] [Related]
13. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ. Clin Ther; 1999 Jan 12; 21(1):172-88. PubMed ID: 10090434 [Abstract] [Full Text] [Related]
15. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin]. Iakovlev SV. Antibiot Khimioter; 1998 Jan 12; 43(10):42-5. PubMed ID: 9825110 [No Abstract] [Full Text] [Related]
16. Clinical experience with OPC-17116 in the treatment of gynaecological infections and its penetration into gynaecological tissues. Japanese Collaborative Study Group of OPC-17116 in Gynaecology. Matsuda S. Drugs; 1995 Jan 12; 49 Suppl 2():395-8. PubMed ID: 8549375 [No Abstract] [Full Text] [Related]